Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.